Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

News | Heart Failure

Patiromer Helps Patients Stay on Optimal Heart Failure Therapy

April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...

April 08, 2022

Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.

News | Structural Heart

Rate of Structural Valve Deterioration Lower with TAVR than with SAVR

April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...

April 08, 2022

News | Cardiovascular Clinical Studies

Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

April 07, 2022

News | Structural Heart

No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

April 07, 2022

Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.

News | Hypertension

Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications

April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...

April 07, 2022

Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.

News | Heart Failure

Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home

April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...

April 06, 2022

Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease.

News | Artificial Intelligence

AI Enables Personalized Treatment of Myocarditis

April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease ...

April 06, 2022

A stroke patient performing upper limb robotic therapy

News | Stroke

Researchers Examine Impact of Robotic Assistance Level in the Upper Limb Rehabilitation of Stroke Survivors

April 4, 2022 – Researches at the Department of Occupational Therapy, College of Health and Human Sciences, Osaka ...

April 04, 2022

Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to researchers at the National Institutes of Health.

News | Heart Failure

Good Hydration May Reduce Long-term Risks for Heart Failure

April 4, 2022 – Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to ...

April 04, 2022

Observational research has suggested that light alcohol consumption may provide heart-related health benefits, but in a large study published in JAMA Network Open, alcohol intake at all levels was linked with higher risks of cardiovascular disease.

News | Heart Failure

Large Study Challenges Theory that Light Alcohol Consumption Benefits Heart Health

April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health ...

April 04, 2022

But scientists at the Medical College of Georgia and Georgia State University also say that the chronic high-salt diet most Americans consume can turn this system against us, resulting in hyperactivity of these neurons, continuing production of this hormone vasopressin, constriction of blood vessels and increasing our risk for common cardiometabolic diseases like high blood pressure and heart disease.

News | Heart Failure

New Clues About How A High-Salt Diet Contributes to Cardiometabolic Diseases Found Deep in the Brain

April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more ...

April 04, 2022

$Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled AIM HIGHer IDE clinical study (Assessment of Implantable CCM in the Heart Failure Group with Higher Ejection Fraction) evaluating CCM therapy for patients who have left ventricular ejection fraction ranging between 40% and 60% inclusive. The study will be conducted across approximately 150 cente$

News | Heart Failure

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer Study

April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart ...

April 04, 2022

News | ACC

Esperion Announces Two NEXLETOL Data Presentations at ACC.22

April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...

April 04, 2022

Significant VHD is commonly encountered in practice, more commonly with advancing age, among women, and identified more frequently in centers offering percutaneous mitral therapies.

News | ACC

egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the US

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...

April 03, 2022

A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.

News | ACC

ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...

April 03, 2022